脓毒症相关急性肾损伤中内皮功能障碍生物标志物的预后与预测价值:儿童脓毒性休克前瞻性观察队列的风险分层分析
该研究为儿童脓毒性休克前瞻性观察队列的二次分析,纳入414例推导队列患儿,主要终点为第3天基于血清肌酐的≥II期KDIGO脓毒症相关急性肾损伤(D3 SA-AKI SCr)。结果显示发生D3 SA-AKI SCr的患儿28天死亡率和需要连续性肾脏替代治疗(CRRT)更差;可溶性血栓调节蛋白(sTM)、血管生成素-2(Angpt-2)和Tie-2独立关联D3 SA-AKI SCr,且Tie-2及Angpt-2/Tie-2比值受D3 SA-AKI SCr与风险分层交互作用影响。逻辑回归模型在高/中PERSEVERE-II风险患儿中预测性能最优,6终末节点CART模型在该亚组推导队列中区分有无D3 SA-AKI SCr的AUROC为0.90,十倍交叉验证为0.77,特异性高;新模型在独立验证集(n=224,其中84例为高/中风险)中区分高与低风险的表现中等。作者认为,待验证后,纳入内皮生物标志物可能有助于未来危重患儿临床试验中的预后和预测富集。
要点
- 在儿童脓毒性休克中,第1天血清sTM、Angpt-2和Tie-2独立关联第3天≥II期KDIGO SA-AKI(基于血清肌酐)。
- 发生D3 SA-AKI SCr的患儿28天死亡率和需要CRRT等临床结局更差。
- Tie-2和Angpt-2/Tie-2比值与D3 SA-AKI SCr的关联受PERSEVERE-II风险分层交互作用影响。
- 在高/中PERSEVERE-II风险患儿中,6终末节点CART模型区分有无D3 SA-AKI SCr的AUROC为0.90,十倍交叉验证为0.77,特异性高。
- 新模型在独立验证集(n=224,其中84例高/中风险)中区分高与低风险的表现中等。
适用人群与场景
- 儿童脓毒性休克前瞻性观察队列的二次分析,推导队列414例。
- 独立验证集224例,其中84例为高/中PERSEVERE-II风险。
- 主要终点为第3天基于血清肌酐的≥II期KDIGO脓毒症相关急性肾损伤(D3 SA-AKI SCr)。
诊断标准与关键阈值
- 脓毒症相关急性肾损伤定义为第3天基于血清肌酐的≥II期KDIGO SA-AKI(D3 SA-AKI SCr)。
- 风险分层基于PERSEVERE-II(前瞻性验证用于预测儿童脓毒症死亡的生物标志物组合)。
红旗征与不能漏的情况
- 发生D3 SA-AKI SCr的患儿28天死亡率和需要CRRT等临床结局更差。
研究设计与关键结果
- 研究类型为儿童脓毒性休克前瞻性观察队列的二次分析,推导队列414例。
- 发生D3 SA-AKI SCr的患儿28天死亡率和需要CRRT更差。
- 第1天血清sTM、Angpt-2和Tie-2独立关联D3 SA-AKI SCr。
- Tie-2和Angpt-2/Tie-2比值受D3 SA-AKI SCr与风险分层交互作用影响。
- 逻辑回归模型在高/中PERSEVERE-II风险患儿中预测性能最优;6终末节点CART模型在该亚组推导队列中区分有无D3 SA-AKI SCr的AUROC为0.90,十倍交叉验证为0.77,特异性高。
- 新模型在独立验证集(n=224,其中84例高/中风险)中区分高与低风险的表现中等。
证据类型、等级与局限
- 证据类型:前瞻性观察队列的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,待验证后,纳入内皮生物标志物可能有助于未来危重患儿临床试验中的预后和预测富集。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis-associated acute kidney injury (SA-AKI) is associated with high morbidity, with no current therapies available beyond continuous renal replacement therapy (CRRT). Systemic inflammation and endothelial dysfunction are key drivers of SA-AKI. We sought to measure differences between endothelial dysfunction markers among children with and without SA-AKI, test whether this association varied across inflammatory biomarker-based risk strata, and develop prediction models to identify those at highest risk of SA-AKI.
METHODS: Secondary analyses of prospective observational cohort of pediatric septic shock. Primary outcome of interest was the presence of ≥ Stage II KDIGO SA-AKI on day 3 based on serum creatinine (D3 SA-AKI SCr). Biomarkers including those prospectively validated to predict pediatric sepsis mortality (PERSEVERE-II) were measured in Day 1 (D1) serum. Multivariable regression was used to test the independent association between endothelial markers and D3 SA-AKI SCr. We conducted risk-stratified analyses and developed prediction models using Classification and Regression Tree (CART), to estimate risk of D3 SA-AKI among prespecified subgroups based on PERSEVERE-II risk.
RESULTS: A total of 414 patients were included in the derivation cohort. Patients with D3 SA-AKI SCr had worse clinical outcomes including 28-day mortality and need for CRRT. Serum soluble thrombomodulin (sTM), Angiopoietin-2 (Angpt-2), and Tie-2 were independently associated with D3 SA-AKI SCr. Further, Tie-2 and Angpt-2/Tie-2 ratios were influenced by the interaction between D3 SA-AKI SCr and risk strata. Logistic regression demonstrated models predictive of D3 SA-AKI risk performed optimally among patients with high- or intermediate-PERSEVERE-II risk strata. A 6 terminal node CART model restricted to this subgroup of patients had an area under the receiver operating characteristic curve (AUROC) 0.90 and 0.77 upon tenfold cross-validation in the derivation cohort to distinguish those with and without D3 SA-AKI SCr and high specificity. The newly derived model performed modestly in a unique set of patients (n = 224), 84 of whom were deemed high- or intermediate-PERSEVERE-II risk, to distinguish those patients with high versus low risk of D3 SA-AKI SCr.
CONCLUSIONS: Endothelial dysfunction biomarkers are independently associated with risk of severe SA-AKI. Pending validation, incorporation of endothelial biomarkers may facilitate prognostic and predictive enrichment for selection of therapeutics in future clinical trials among critically ill children.
参考来源
- Atreya MR, Cvijanovich NZ, Fitzgerald JC, et al. Prognostic and predictive value of endothelial dysfunction biomarkers in sepsis-associated acute kidney injury: risk-stratified analysis from a prospective observational cohort of pediatric septic shock. Crit Care. 2023. PMID: 37400882. doi:10.1186/s13054-023-04554-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。